Time Restricted Eating for Polycystic Ovary Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores different eating strategies to assist women with polycystic ovary syndrome (PCOS), a condition that can lead to fertility issues and other health problems. Participants will follow either a time-restricted eating (TRE) plan, eating freely only between 1:00 pm and 7:00 pm, or a daily calorie restriction (CR) plan, reducing calories by 25%. A control group will maintain their usual eating habits. Women with PCOS who are overweight or obese may be suitable for this study. As an unphased trial, this study provides a unique opportunity to investigate innovative eating strategies that could enhance health and well-being.
Will I have to stop taking my current medications?
Yes, you will need to stop taking certain medications that affect the study outcomes, such as oral contraceptives, weight loss drugs, insulin-sensitizing agents, androgen antagonists, anti-seizure, or antipsychotic medications, at least 2 months before starting the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that time-restricted eating (TRE) is generally safe and easy to follow. Studies have found that eating within an eight-hour window can improve health and reduce insulin resistance in women with PCOS, allowing them to try this eating pattern safely without major side effects.
Calorie restriction (CR), which involves eating 25% fewer calories each day, is also a common and safe method for weight loss. Research indicates that CR can help improve PCOS symptoms by supporting long-term weight loss. Both TRE and CR have been extensively studied and are considered safe for managing weight and PCOS symptoms. Participants in these studies did not report significant negative effects, demonstrating that both methods are well-tolerated.12345Why are researchers excited about this trial's treatments?
Researchers are excited about time-restricted eating (TRE) and calorie restriction (CR) for managing Polycystic Ovary Syndrome (PCOS) because these approaches offer a fresh take on dietary interventions. Unlike traditional treatments involving medications like hormonal birth control or metformin, TRE involves an 18-hour daily fasting period, which may improve metabolic health by aligning eating patterns with circadian rhythms. Meanwhile, calorie restriction focuses on a daily 25% reduction in energy intake, which could help with weight management and insulin sensitivity. These methods are non-pharmacological, potentially minimizing side effects associated with drugs, and they empower individuals with PCOS to manage their condition through lifestyle changes.
What evidence suggests that this trial's treatments could be effective for PCOS?
This trial will compare different dietary approaches for managing symptoms of polycystic ovary syndrome (PCOS). Research has shown that time-restricted eating (TRE), one of the approaches tested in this trial, can help manage PCOS symptoms. Specifically, studies have found that an 8-hour TRE plan can significantly lower body mass index (BMI) and the waist-to-hip ratio in women with PCOS. It also helps control blood sugar levels, which is crucial for managing PCOS. Another approach in this trial is calorie restriction (CR), known to aid in weight loss, improve insulin resistance, and regulate menstrual cycles in women with PCOS. Both methods show promise for improving symptoms, but TRE might be easier to follow since it doesn't involve counting calories.13567
Who Is on the Research Team?
Krista Varady, PhD
Principal Investigator
University of Illinois Chicago
Are You a Good Fit for This Trial?
This trial is for women aged 18-40 with obesity and PCOS, diagnosed by the Rotterdam criteria. Participants should have a BMI between 25-50 kg/m2 and not be postmenopausal or have diabetes, eating disorders, or recent use of certain medications that affect weight and hormones. Smokers, pregnant women, high-intensity athletes, and those without Wi-Fi are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to 6-hour TRE, CR, or control group for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Calorie Restriction
- Control
- Time Restricted Eating
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor